If I had to chose one stock to own this next year you are looking at it. Long since 1.90's. Chart is setting up perfectly for 3/22 Data readout. Broke resistance today. Held up beautifully in market downturn. If this completes a phase 2 trial for Factor D I will be shocked. Strong buyout candidate for rare disease field.
I have also done a DD on this interesting company and believe that may be, in the medium term (around 3/4 years), a multi bagger from 2x to 13x.
No idea about the short term I am not a technical analyst.
shlobby
⋅
@Break-point I see it as an early ALXN late 2000s. holding long here until something changes course but management seems to be firing on all cylinders pre fda approval to now
Break-point
⋅
@shlobby, That would be great, definitely in my opinion make sense to keep it for the long terms. Too difficult to time the market in and out.